-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Moderna to Present at Upcoming Conference in November 2026
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Medical Care Technologies Inc. (OTCID:MDCE) Subsidiaries to Manage $20 Million in Private Collectibles Assets
-
Opportunistic Trader ETF(WZRD) to Delist and Liquidate
-
LiveOne (Nasdaq: LVO) Releases Preliminary H1 Fiscal 2027 Results: $37.3 Million in Revenue and Record Audio Adjusted EBITDA* of $7.8 Million, Up 619% Year-Over-Year
-
Critics and Listeners Agree: Eylsia Nicolas' "The Wedding Song" Nominated for GlacerFM's Best Pop Song 2026; Second Consecutive Listener's Choice Nomination Follows Widespread Critical Recognition and Growing Global Audience
-
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents
-
Guard Home Warranty Launches Claims 2.0: A Real US-Based Person in 16 Seconds, Claims Reimbursed Instantly
-
Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian
MD+DI Names Babson Diagnostics, 2024 Medtech Company of the Year
MD+DI editors mark Babson Diagnostics as a notable true solution to deliver simplified blood testing through BetterWay.
Medical Device & Diagnostic Industry (MD+DI), the leading business-to-business media brand covering the medtech industry, has named Babson Diagnostics its 2024 Medtech Company of the Year.
For more than a decade, MD+DI's editors have recognized the Medtech Company of the Year annually to highlight medical device or diagnostic industry players that have risen above the competition with standout technologies, exceptional business results or other achievements. Past winners have included Abbott Laboratories, Boston Scientific and Hologic.
The Medtech Company of the Year selected for 2024 is Babson Diagnostics, in recognition of its BetterWay blood tests, which uses a pea-sized sample of blood collected from a fingertip without the need for a phlebotomist. BetterWay testing launched this year at select locations in Austin, TX, and starts at just $15.
"Babson Diagnostics has tremendously overcome much industry skepticism, due to challenges infamously from other organizations in the past claiming to offer similar premises but never fulfilling the expectations of a seamless, blood testing experience for patients," says Omar Ford, Editor-in-Chief, MD+DI. "BetterWay is a brilliantly simple solution that delivers what was once the dream, to genuinely increase accessibility to patient care, efficiency and personalization, all while being up to half the cost of other self-pay blood tests."
In addition to launching BetterWay tests this past summer, Babson Diagnostics also announced a strategic investment from BD in October. Other milestones for the company this year included validation of its proprietary hand-warming device, which supports improved collection of capillary blood samples, as well as the establishment of a dedicated clinician relations team.
"Almost every conversation we have, some doubt comes into the picture," shares Eric Olson, founder and COO of Babson Diagnostics. "When somebody is trying to understand what we are doing, they always want to know how this compares to other technologies. We realized early on that the way that you deal with that is through science and transparency. It is not enough to just say that we are different than what has happened in the past, in this industry you have to prove it, and we have done just that."
Babson Diagnostics was also selected as The Readers' Choice Medtech Company of the Year, through MD+DI's audience's online vote.
The nine other finalists for the 2024 Medtech Company of the Year were: Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Fractyl, Intuitive Surgical, Medtronic, Senseonics, Solventum and Stryker.
Stay up to date with the latest trends and topics for medical devices and in vitro diagnostic products at: mddionline.com/
About MD+DI
Medical Device and Diagnostic Industry (MD+DI) is the primary resource for manufacturers of medical devices and in vitro diagnostic products. Its mission is to help medtech industry professionals develop, design, and manufacture products that comply with complex and demanding regulations and evolving market requirements. For more than 40 years, MD+DI's editorial quality and reliability have won it an unparalleled degree of trust from the industry. Some of the best and brightest experts in medtech contribute to MD+DI, and many of their articles have become standards of reference for the medical device industry.
Through its associated Qmed+ directory, MD+DI connects readers with qualified suppliers offering the latest products, services and equipment for the medtech industry. As a prominent part of the global Informa Markets - Engineering portfolio, MD+DI is also the official media partner of the MD&M West, MD&M Minneapolis, MD&M East, MD&M South, MEDevice Boston, and MEDevice Silicon Valley events.
Our broader network of related events and media brands serves high-growth industries across the advanced manufacturing sector.
About Informa Markets Engineering
Informa Markets Engineering is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa Markets, a subsidiary of Informa plc (LON:INF), the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
Media Contact
Informa Markets Engineering PR
[email protected]
SOURCE: INFORMA MARKETS - ENGINEERING
P.M.Smith--AMWN